Repository logo
 

Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity

Published version
Peer-reviewed

Change log

Authors

Thomas, DC 
Clare, S 
Sowerby, JM 
Pardo, M 
Juss, JK 

Abstract

The phagocyte respiratory burst is crucial for innate immunity. The transfer of electrons to oxygen is mediated by a membrane-bound heterodimer, comprising gp91phox and p22phox subunits. Deficiency of either subunit leads to severe immunodeficiency. We describe Eros (essential for reactive oxygen species), a protein encoded by the previously undefined mouse gene bc017643, and show that it is essential for host defense via the phagocyte NAPDH oxidase. Eros is required for expression of the NADPH oxidase components, gp91phox and p22phox. Consequently, Eros-deficient mice quickly succumb to infection. Eros also contributes to the formation of neutrophil extracellular traps (NETS) and impacts on the immune response to melanoma metastases. Eros is an ortholog of the plant protein Ycf4, which is necessary for expression of proteins of the photosynthetic photosystem 1 complex, itself also an NADPH oxio-reductase. We thus describe the key role of the previously uncharacterized protein Eros in host defense.

Description

Keywords

Animals, Cytochrome b Group, Endoplasmic Reticulum, HEK293 Cells, Humans, Immunity, Innate, Macrophages, Membrane Glycoproteins, Membrane Proteins, Mice, Mice, Inbred C57BL, NADPH Oxidase 2, NADPH Oxidases, Neutrophils, Phagocytes, Phagocytosis, Reactive Oxygen Species, Respiratory Burst

Journal Title

The Journal of Experimental Medicine

Conference Name

Journal ISSN

0022-1007
1540-9538

Volume Title

214

Publisher

Rockefeller University Press
Sponsorship
Wellcome Trust (102770/Z/13/Z)
Medical Research Council (MR/L019027/1)
Wellcome Trust (105920/Z/14/Z)
Wellcome Trust (079895/Z/06/B)
Medical Research Council (MR/P502091/1)
D.C. Thomas was funded by a Wellcome Trust/CIMR Next Generation Fellowship, a National Institute for Health Research (NIHR) Clinical Lectureship, and a Starter Grant for Clinical Lecturers (Academy of Medical Sciences). K.G.C. Smith was funded by funded by the Medical Research Council (program grant MR/L019027) and is a Wellcome Investigator and a NIHR Senior Investigator. S. Clare and G. Dougan were funded by the Wellcome Trust (grant 098051). The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895). J.C.L is funded by a Wellcome Intermediate Clinical Fellowship 105920/2/14/2.